$REGN
REGENERON PHARMACEUTICALS, INC.

2019 Q4 Form 10-K Financial Statement

#000153217620000008 Filed on February 07, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4 2018 Q3
Revenue $1.864B $1.928B $1.664B
YoY Change -3.34% 21.82% 10.85%
Cost Of Revenue $223.9M $117.2M $110.4M
YoY Change 91.04% 10.88% 137.99%
Gross Profit $1.946B $1.811B $1.553B
YoY Change 7.46% 22.61% 6.79%
Gross Profit Margin 104.41% 93.92% 93.36%
Selling, General & Admin $586.8M $491.3M $369.2M
YoY Change 19.44% 19.86% 20.35%
% of Gross Profit 30.16% 27.13% 23.77%
Research & Development $683.1M $606.3M $557.0M
YoY Change 12.67% 14.83% 5.14%
% of Gross Profit 35.11% 33.49% 35.86%
Depreciation & Amortization $54.30M $42.80M $35.40M
YoY Change 26.87% 24.06% -6.35%
% of Gross Profit 2.79% 2.36% 2.28%
Operating Expenses $1.270B $1.093B $926.2M
YoY Change 16.24% 16.48% 10.72%
Operating Profit $675.7M $718.1M $626.9M
YoY Change -5.9% 33.28% 11.96%
Interest Expense $53.20M -$7.300M $7.400M
YoY Change -828.77% 21.67% 19.7%
% of Operating Profit 7.87% -1.02% 1.18%
Other Income/Expense, Net $160.9M -$34.50M $9.000M
YoY Change -566.38% -256.82% 58.48%
Pretax Income $889.8M $676.2M $635.9M
YoY Change 31.59% 21.88% 12.43%
Income Tax $97.80M -$88.10M $41.20M
% Of Pretax Income 10.99% -13.03% 6.48%
Net Earnings $792.0M $820.4M $594.7M
YoY Change -3.46% 372.85% 53.15%
Net Earnings / Revenue 42.5% 42.56% 35.75%
Basic Earnings Per Share $7.25 $7.58 $5.50
Diluted Earnings Per Share $6.93 $7.15 $5.17
COMMON SHARES
Basic Shares Outstanding 108.0M shares
Diluted Shares Outstanding 115.1M shares

Balance Sheet

Concept 2019 Q4 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.214B $2.810B $2.192B
YoY Change 14.38% 99.29% 58.96%
Cash & Equivalents $1.618B $1.468B $1.088B
Short-Term Investments $1.597B $1.342B $1.104B
Other Short-Term Assets $788.0M $572.0M $644.0M
YoY Change 37.76% 30.89% 80.39%
Inventory $1.416B $1.151B $1.040B
Prepaid Expenses
Receivables $2.100B $1.724B $1.666B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.689B $6.448B $5.720B
YoY Change 19.26% 48.73% 38.3%
LONG-TERM ASSETS
Property, Plant & Equipment $2.890B $2.576B $2.524B
YoY Change 12.21% 9.21% 10.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.312B $1.801B $1.874B
YoY Change 83.9% 21.2% 41.22%
Other Assets $144.7M $127.4M $125.2M
YoY Change 13.58% 63.54% 241.9%
Total Long-Term Assets $7.116B $5.287B $5.086B
YoY Change 34.6% 19.36% 11.4%
TOTAL ASSETS
Total Short-Term Assets $7.689B $6.448B $5.720B
Total Long-Term Assets $7.116B $5.287B $5.086B
Total Assets $14.81B $11.73B $10.81B
YoY Change 26.17% 33.89% 24.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $418.1M $218.2M $172.0M
YoY Change 91.61% 22.45% 11.69%
Accrued Expenses $1.087B $772.0M $782.0M
YoY Change 40.8% 21.19% 45.35%
Deferred Revenue $591.7M $452.5M
YoY Change 30.76% 41.36%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.097B $1.443B $1.417B
YoY Change 45.31% 27.06% 24.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $709.0M $707.0M
YoY Change -100.0% 0.85% 0.71%
Other Long-Term Liabilities $317.7M $361.7M $194.0M
YoY Change -12.16% 137.96% 54.95%
Total Long-Term Liabilities $317.7M $361.7M $194.0M
YoY Change -12.16% 137.96% 54.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.097B $1.443B $1.417B
Total Long-Term Liabilities $317.7M $361.7M $194.0M
Total Liabilities $3.716B $2.977B $2.937B
YoY Change 24.8% 13.62% 10.86%
SHAREHOLDERS EQUITY
Retained Earnings $7.380B $5.254B $4.434B
YoY Change 40.45% 78.31% 59.88%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $739.9M $396.4M $396.4M
YoY Change 86.65% 25.36% 25.34%
Treasury Stock Shares 4.860M shares 3.990M shares 3.990M shares
Shareholders Equity $11.09B $8.757B $7.868B
YoY Change
Total Liabilities & Shareholders Equity $14.81B $11.73B $10.81B
YoY Change 26.17% 33.89% 24.19%

Cashflow Statement

Concept 2019 Q4 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income $792.0M $820.4M $594.7M
YoY Change -3.46% 372.85% 53.15%
Depreciation, Depletion And Amortization $54.30M $42.80M $35.40M
YoY Change 26.87% 24.06% -6.35%
Cash From Operating Activities $787.4M $728.8M $453.0M
YoY Change 8.04% 28.56% 9.18%
INVESTING ACTIVITIES
Capital Expenditures -$139.0M -$85.50M -$106.2M
YoY Change 62.57% -20.54% 77.89%
Acquisitions
YoY Change
Other Investing Activities -$69.70M -$180.4M -$180.5M
YoY Change -61.36% -20.91% -39.69%
Cash From Investing Activities -$208.7M -$265.9M -$286.7M
YoY Change -21.51% -20.82% -20.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -345.7M -83.00M 3.700M
YoY Change 316.51% -60.57% -145.12%
NET CHANGE
Cash From Operating Activities 787.4M 728.8M 453.0M
Cash From Investing Activities -208.7M -265.9M -286.7M
Cash From Financing Activities -345.7M -83.00M 3.700M
Net Change In Cash 233.0M 379.9M 170.0M
YoY Change -38.67% 1744.17% 254.91%
FREE CASH FLOW
Cash From Operating Activities $787.4M $728.8M $453.0M
Capital Expenditures -$139.0M -$85.50M -$106.2M
Free Cash Flow $926.4M $814.3M $559.2M
YoY Change 13.77% 20.73% 17.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown,
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
CY2019 dei City Area Code
CityAreaCode
914
CY2019 dei Local Phone Number
LocalPhoneNumber
847-7000
CY2019 dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
CY2019 dei Trading Symbol
TradingSymbol
REGN
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000872589
CY2019Q4 regn Finance Lease Rightof Use Asset Accumulated Amortization
FinanceLeaseRightofUseAssetAccumulatedAmortization
76100000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2017Q1 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3990021 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4860123 shares
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
0-19034
CY2019 dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
32929000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1617800000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1467700000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1596500000 USD
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1342200000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000000.0 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1723700000 USD
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
260600000 USD
CY2018Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
226400000 USD
CY2019Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
311600000 USD
CY2018Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
293100000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1415500000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
387100000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
243300000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
7689100000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6447600000 USD
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3256800000 USD
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1755000000.0 USD
CY2019Q4 regn Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2890400000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2575800000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
824200000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
828700000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
144700000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
127400000 USD
CY2019Q4 us-gaap Assets
Assets
14805200000 USD
CY2018Q4 us-gaap Assets
Assets
11734500000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
418100000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
218200000 USD
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1086800000 USD
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
772100000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2096600000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1442800000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
713900000 USD
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
708500000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
286000000.0 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
361700000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3715500000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
2977200000 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4428600000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3911600000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7379800000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5254300000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21100000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12300000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
739900000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
396400000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14805200000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11734500000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7863400000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6710800000 USD
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5872200000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3036600000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2186100000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2075100000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1834800000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1556200000 USD
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1320400000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
5653600000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
4176400000 USD
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
3792600000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
2209800000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
2534400000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
2079600000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
249500000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
47300000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000000.0 USD
CY2019 us-gaap Interest Expense
InterestExpense
30200000 USD
CY2018 us-gaap Interest Expense
InterestExpense
28200000 USD
CY2017 us-gaap Interest Expense
InterestExpense
25100000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
219300000 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19100000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1100000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2429100000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2553500000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2078500000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
313300000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109100000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
880000000.0 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
2115800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2444400000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
1198500000 USD
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
19.38
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
22.65
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.27
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
18.46
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
21.29
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.34
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107900000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106300000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114600000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114800000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115900000 shares
CY2019 us-gaap Net Income Loss
NetIncomeLoss
2115800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2444400000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
1198500000 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35900000 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000000.0 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12700000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2500000 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
700000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
800000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2149200000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2438100000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1212000000.0 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
4449300000 USD
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
240600000 USD
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
301700000 USD
CY2017 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
19400000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
524600000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
1198500000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
13400000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6144100000 USD
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
114200000 USD
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
187200000 USD
CY2018 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
26900000 USD
CY2018 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
80200000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
444800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2444400000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6300000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
213200000 USD
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
188000000.0 USD
CY2019 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
38100000 USD
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
356700000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
466900000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
2115800000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
33400000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
2115800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2444400000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
1198500000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
210300000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
148200000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145500000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
464300000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
427400000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
507300000 USD
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
29300000 USD
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-12100000 USD
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-63500000 USD
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
130600000 USD
CY2018 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
140000000.0 USD
CY2017 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-318800000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
473100000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
268900000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
362700000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
335500000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
387900000 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
314200000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
130400000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
55700000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
113300000 USD
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
294000000.0 USD
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-194500000 USD
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-113100000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
444500000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
210000000.0 USD
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23200000 USD
CY2019 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
314200000 USD
CY2018 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-249300000 USD
CY2017 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
108600000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2430000000.0 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2195100000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1307100000 USD
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3202400000 USD
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1845500000 USD
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1277200000 USD
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1604200000 USD
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
775600000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
544600000 USD
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
429600000 USD
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
383100000 USD
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
272600000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10000000.0 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2027800000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1463000000.0 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1005200000 USD
CY2018 us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
0 USD
CY2017 us-gaap Proceeds From Long Term Capital Lease Obligations
ProceedsFromLongTermCapitalLeaseObligations
57000000.0 USD
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
19900000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
211800000 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
114500000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
240200000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
188000000.0 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
187200000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
301700000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
275900000 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4400000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-252100000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-77100000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24400000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150100000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
655000000.0 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
277500000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825200000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
547700000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825200000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
25000000.0 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
22300000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
18700000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
342300000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
205600000 USD
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
754800000 USD
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments which potentially expose the Company to concentrations of credit risk consist of cash, cash equivalents, certain investments, and accounts receivable. In accordance with the Company's policies, the Company mandates asset diversification and monitors exposure with its counterparties. </span></div>Concentrations of credit risk with respect to accounts receivable are significant. The Company has a concentration of credit risk associated with the receivables due from its collaborators Bayer, Sanofi, and Teva. The Company is also subject to credit risk with accounts receivable from its product sales, which are due from several distributors and specialty pharmacies (the Company's customers).
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2018 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
472800000 USD
CY2019 regn Revenue From Contract With Customer Period Prior To Products Expiration Date For Returns Accepted
RevenueFromContractWithCustomerPeriodPriorToProductsExpirationDateForReturnsAccepted
P3M
CY2019 regn Revenue From Contract With Customer Period Up To Products Expiration Date For Returns Accepted
RevenueFromContractWithCustomerPeriodUpToProductsExpirationDateForReturnsAccepted
P6M
CY2019 regn Collaboration Revenue For Non Refundable Up Front Payments Development Milestones And Payments For Development Activities For Which Used An Input Method
CollaborationRevenueForNonRefundableUpFrontPaymentsDevelopmentMilestonesAndPaymentsForDevelopmentActivitiesForWhichUsedAnInputMethod
497600000 USD
CY2018 regn Collaboration Revenue For Non Refundable Up Front Payments Development Milestones And Payments For Development Activities For Which Used An Input Method
CollaborationRevenueForNonRefundableUpFrontPaymentsDevelopmentMilestonesAndPaymentsForDevelopmentActivitiesForWhichUsedAnInputMethod
837700000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
45800000 USD
CY2017 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
408300000 USD
CY2017 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
368800000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85300000 USD
CY2018 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
478900000 USD
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
91400000 USD
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
118300000 USD
CY2018 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-41900000 USD
CY2019 us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
727900000 USD
CY2019 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
663200000 USD
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
156100000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4206300000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28500000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
300000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4234500000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3026600000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000000.0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18400000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1596500000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1342200000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2638000000.0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1667000000.0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4234500000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
274500000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
300000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
43100000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
317600000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1482600000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6100000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
900700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2383300000 USD
CY2017 regn Available For Sale Equity Securities Net Unrealized Gains Losses Recognized In Other Comprehensive Income Loss
AvailableForSaleEquitySecuritiesNetUnrealizedGainsLossesRecognizedInOtherComprehensiveIncomeLoss
14700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
18400000 USD
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2018Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
45500000 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
55600000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
216300000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
226800000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
727700000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
571100000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
70600000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24400000 USD
CY2019Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
400900000 USD
CY2018Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
328900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1415500000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
73800000 USD
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
12500000 USD
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
20900000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3812800000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3304500000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
922400000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
728700000 USD
CY2019Q4 regn Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2890400000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2575800000 USD
CY2019 regn Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
205200000 USD
CY2018 regn Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
144100000 USD
CY2017 regn Depreciation Depletion And Amortization Excluding Intangible Assets
DepreciationDepletionAndAmortizationExcludingIntangibleAssets
142200000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
344400000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
261800000 USD
CY2019Q4 regn Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
142700000 USD
CY2018Q4 regn Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
142200000 USD
CY2019Q4 regn Accruedsalesrelatedchargesdeductionsandroyalties
Accruedsalesrelatedchargesdeductionsandroyalties
249000000.0 USD
CY2018Q4 regn Accruedsalesrelatedchargesdeductionsandroyalties
Accruedsalesrelatedchargesdeductionsandroyalties
182700000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
49400000 USD
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
20800000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301300000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
164600000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1086800000 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
772100000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
591700000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
452500000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
619000000.0 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
464200000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7600000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
22200000 USD
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
660100000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
713900000 USD
CY2018Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
723900000 USD
CY2018Q4 us-gaap Capital Leases Net Investment In Direct Financing Leases Accumulated Amortization
CapitalLeasesNetInvestmentInDirectFinancingLeasesAccumulatedAmortization
61700000 USD
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14400000 USD
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
27600000 USD
CY2019 regn Finance Lease Cost
FinanceLeaseCost
42000000.0 USD
CY2019 regn Finance Lease Remaining Lease Term
FinanceLeaseRemainingLeaseTerm
P2Y2M1D
CY2019Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0305
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6600000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
21900000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3300000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
725400000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2000000.0 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2300000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4300000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
26100000 USD
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
769500000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2500000 USD
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
50100000 USD
CY2019Q4 regn Lessee Operating Lease Liability Debt Financing Costs
LesseeOperatingLeaseLiabilityDebtFinancingCosts
0 USD
CY2019Q4 regn Lessee Finance Lease Liability Debt Financing Costs
LesseeFinanceLeaseLiabilityDebtFinancingCosts
5500000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
23600000 USD
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
713900000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
10400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
26400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3800000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
28400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
27900000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2200000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
7000000.0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1500000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4100000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
25400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
89700000 USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2019Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.0 USD
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
722596 shares
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
254000000.0 USD
CY2007 regn Number Of Demand Rights To Require The Company To Conduct Registered Underwritten Public Offering
NumberOfDemandRightsToRequireTheCompanyToConductRegisteredUnderwrittenPublicOffering
3 demand_right
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4800000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
38100000 USD
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
27000000.0 USD
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
19600000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2011200000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
2151700000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1964700000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
417900000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
401800000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
113800000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2429100000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2553500000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2078500000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
444600000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
223700000 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
560300000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1900000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4800000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-4100000 USD
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-2600000 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
20600000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
443900000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
249100000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
561000000.0 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-132000000.0 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
687600000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
317100000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1700000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1900000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1300000 USD
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
3100000 USD
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-825700000 USD
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
3200000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-130600000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-140000000.0 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
319000000.0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
313300000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109100000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
880000000.0 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.046
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.026
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.025
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.025
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.090
CY2019 regn Effective Income Tax Rate Reconciliation Deduction Foreign Intangible Income Percent
EffectiveIncomeTaxRateReconciliationDeductionForeignIntangibleIncomePercent
0.016
CY2018 regn Effective Income Tax Rate Reconciliation Deduction Foreign Intangible Income Percent
EffectiveIncomeTaxRateReconciliationDeductionForeignIntangibleIncomePercent
0.010
CY2017 regn Effective Income Tax Rate Reconciliation Deduction Foreign Intangible Income Percent
EffectiveIncomeTaxRateReconciliationDeductionForeignIntangibleIncomePercent
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.010
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.019
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.007
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
0.007
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
0.006
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit
EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit
0.017
CY2019 regn Effective Income Tax Rate Reconciliation Sale Of Non Inventory Related Assets Between Foreign Subsidiaries Percent
EffectiveIncomeTaxRateReconciliationSaleOfNonInventoryRelatedAssetsBetweenForeignSubsidiariesPercent
0
CY2018 regn Effective Income Tax Rate Reconciliation Sale Of Non Inventory Related Assets Between Foreign Subsidiaries Percent
EffectiveIncomeTaxRateReconciliationSaleOfNonInventoryRelatedAssetsBetweenForeignSubsidiariesPercent
-0.063
CY2017 regn Effective Income Tax Rate Reconciliation Sale Of Non Inventory Related Assets Between Foreign Subsidiaries Percent
EffectiveIncomeTaxRateReconciliationSaleOfNonInventoryRelatedAssetsBetweenForeignSubsidiariesPercent
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.027
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.157
CY2019 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities
EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
0.026
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.009
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.021
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.129
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.043
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.423
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.043
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.423
CY2017Q4 us-gaap Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit
326200000 USD
CY2018 us-gaap Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Income Tax Expense Benefit
TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
-68000000.0 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
519700000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
458200000 USD
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
192000000.0 USD
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
107800000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
75900000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
53300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
22000000.0 USD
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
20200000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
33300000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
809600000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
672800000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7000000.0 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
802600000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
672800000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
11200000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2700000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
791400000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
670100000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
210800000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
189500000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
146200000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
189500000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
146200000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
117200000 USD
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
37900000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
51400000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
49000000.0 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
7200000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
5600000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
5600000 USD
CY2019 regn Unrecognized Tax Benefits Decrease Resulting From Settlements With Taxing Authorities And Reduction Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsDecreaseResultingFromSettlementsWithTaxingAuthoritiesAndReductionResultingFromLapseOfApplicableStatuteOfLimitations
9400000 USD
CY2018 regn Unrecognized Tax Benefits Decrease Resulting From Settlements With Taxing Authorities And Reduction Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsDecreaseResultingFromSettlementsWithTaxingAuthoritiesAndReductionResultingFromLapseOfApplicableStatuteOfLimitations
13700000 USD
CY2017 regn Unrecognized Tax Benefits Decrease Resulting From Settlements With Taxing Authorities And Reduction Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsDecreaseResultingFromSettlementsWithTaxingAuthoritiesAndReductionResultingFromLapseOfApplicableStatuteOfLimitations
14400000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
210800000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
189500000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
146200000 USD
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
100000000.0 USD
CY2018Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
30000000.0 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
2115800000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
2444400000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
1198500000 USD
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107900000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106300000 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114600000 shares
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114800000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115900000 shares
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
19.38
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
22.65
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.27
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
18.46
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
21.29
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.34
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1617800000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1467700000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
812700000 USD
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825200000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2019Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
133700000 USD
CY2018Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
54500000 USD
CY2017Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
41800000 USD
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
201200000 USD
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1711800000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1933700000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2048400000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2169500000 USD
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
1231800000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
1618100000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
1309900000 USD
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
1493800000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
461100000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
792000000.0 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.23
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.25
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.99
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.68
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.86
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.93
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1511500000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1608000000.0 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1663500000 USD
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1927800000 USD
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
944300000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
985800000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
1036600000 USD
CY2018Q4 us-gaap Costs And Expenses
CostsAndExpenses
1209700000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
478000000.0 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594700000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
820400000 USD
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.44
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.12
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.50
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.58
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.16
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.82
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.17
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.15

Files In Submission

Name View Source Status
0001532176-20-000008-index-headers.html Edgar Link pending
0001532176-20-000008-index.html Edgar Link pending
0001532176-20-000008.txt Edgar Link pending
0001532176-20-000008-xbrl.zip Edgar Link pending
chart-1523b1e8fa145a93979.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R9999.htm Edgar Link pending
regn-123119x10k.htm Edgar Link pending
regn-123119x10k_htm.xml Edgar Link completed
regn-20191231.xsd Edgar Link pending
regn-20191231_cal.xml Edgar Link unprocessable
regn-20191231_def.xml Edgar Link unprocessable
regn-20191231_lab.xml Edgar Link unprocessable
regn-20191231_pre.xml Edgar Link unprocessable
regn-ex10102secondamen.htm Edgar Link pending
regn-ex10217ar2014ltip.htm Edgar Link pending
regn-ex10218ar2014ltip.htm Edgar Link pending
regn-ex10219ar2014ltip.htm Edgar Link pending
regn-ex10220ar2014ltip.htm Edgar Link pending
regn-ex10221ar2014ltip.htm Edgar Link pending
regn-ex10222ar2014ltip.htm Edgar Link pending
regn-ex211x12312019x10k.htm Edgar Link pending
regn-ex231x12312019x10k.htm Edgar Link pending
regn-ex311x12312019x10k.htm Edgar Link pending
regn-ex312x12312019x10k.htm Edgar Link pending
regn-ex32x12312019x10k.htm Edgar Link pending
regn-ex41xdescriptiono.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending